VeriMomoriganum majorana leaf extract est-il sûr pendant la grossesse ?
No harmonised CLP reproductive classifications for Origanum majorana leaf extract and no SCCS/CIR safety assessment identifying reproductive risks. PubMed literature does not show human teratogenic or reproductive toxicity data for the extract; botanical constituents (terpenes, phenolics) do not individually trigger harmonised reproductive flags. Dermal absorption from topical use is expected to be low but measurable, so exposure is scored as low (evidence: CosIng/ECHA entries list the extract without restrictions; PubChem lists constituent volatiles but no reproductive alerts).
Pregnancy-safe products containing origanum majorana leaf extract
Related ingredients
Frequently asked questions
- origanum majorana leaf extract est-il sûr pendant la grossesse ?
- No harmonised CLP reproductive classifications for Origanum majorana leaf extract and no SCCS/CIR safety assessment identifying reproductive risks. PubMed literature does not show human teratogenic or reproductive toxicity data for the extract; botanical constituents (terpenes, phenolics) do not individually trigger harmonised reproductive flags. Dermal absorption from topical use is expected to be low but measurable, so exposure is scored as low (evidence: CosIng/ECHA entries list the extract without restrictions; PubChem lists constituent volatiles but no reproductive alerts).
- origanum majorana leaf extract est-il sûr pendant l'allaitement ?
- No evidence of reproductive or lactation-specific toxicity in authoritative sources. No harmonised classification or SCCS/CIR concern. Potential for low dermal absorption exists, but no data showing transfer into breastmilk; exposure scored as low (CosIng/ECHA/PubChem; absence of CIR/SCCS warnings).
- origanum majorana leaf extract est-il sûr pour la peau de bébé ?
- No infant-specific safety signals or harmonised reproductive classifications. However, because infant skin has higher permeability and surface-area-to-weight ratio, exposure scoring is increased by +1 (adult e=1 → infant e=2). No data support increased hazard or a specific reproductive mechanism in infants.
- Comment VeriMom évalue-t-il origanum majorana leaf extract ?
- VeriMom évalue origanum majorana leaf extract à 93/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à origanum majorana leaf extract pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à origanum majorana leaf extract basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.